NCT04526314

Brief Summary

The objective of this study was to assess survival trends in elderly patients with stage III colon cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
308

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 25, 2020

Completed
Last Updated

August 25, 2020

Status Verified

August 1, 2020

Enrollment Period

2 years

First QC Date

August 15, 2020

Last Update Submit

August 24, 2020

Conditions

Colon Adenocarcinoma

Keywords

stage 3 colon cancerelderlysurvivalsurgerychemotherapy

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    months

    2007-2014

Study Arms (2)

Stage 3 with adjuvant chemotherapy

Other: observational

Stage 3 without adjuvant chemotherapy

Other: observational

Interventions

observationalOTHER

observational

Stage 3 with adjuvant chemotherapyStage 3 without adjuvant chemotherapy

Eligibility Criteria

Age80 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

clinical data

You may qualify if:

  • Stage 3 colon adenocarcinoma

You may not qualify if:

  • Rectal tumors
  • Patients receiving neo-adjuvant chemotherapy or radiotherapy
  • Tumours of the appendix
  • Tumours with histology other than adenocarcinoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Registre de tumeurs digestives du Finistère

Brest, 29200, France

Location

Related Publications (1)

  • Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Queneherve L. Prognostic factors for stage III colon cancer in patients 80 years of age and older. Int J Colorectal Dis. 2021 Apr;36(4):811-819. doi: 10.1007/s00384-021-03861-6. Epub 2021 Feb 2.

    PMID: 33528749DERIVED

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Michel Robaskiewicz, MD PhD

    REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2020

First Posted

August 25, 2020

Study Start

January 1, 2018

Primary Completion

January 1, 2020

Study Completion

July 1, 2020

Last Updated

August 25, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)